The reported statements, read against the company's own industry.
Financials view
Market Capitalization
7.30BUSD
vs all stocks (USD)
Updated Jul 19, 2026
Trailing P/E
29.76x
vs Medical Care Facilities peers
Updated Jul 19, 2026
Revenue (TTM)
5.43BUSD
vs all stocks (USD)
Updated Jul 19, 2026
Profit Margin
4.49%
vs Medical Care Facilities peers
Updated Jul 19, 2026
Beta
-0.0810x
vs all stocks
Updated Jul 19, 2026
52-Week Change
296.98%
vs all stocks
Updated Jul 19, 2026
Market Capitalization
7.30BUSD
vs all stocks (USD)
Updated Jul 19, 2026
Enterprise Value
10.56BUSD
vs all stocks (USD)
Updated Jul 19, 2026
Trailing P/E
29.76x
vs Medical Care Facilities peers
Updated Jul 19, 2026
Forward P/E
18.85x
vs Medical Care Facilities peers
Updated Jul 19, 2026
PEG Ratio
0.1623x
vs Medical Care Facilities peers
Updated Jul 19, 2026
Price to Sales (TTM)
1.34x
vs Medical Care Facilities peers
Updated Jul 19, 2026
Price to Book (MRQ)
6.99x
vs Medical Care Facilities peers
Updated Jul 19, 2026
Enterprise to Revenue
1.95x
vs Medical Care Facilities peers
Updated Jul 19, 2026
Enterprise to EBITDA
23.87x
vs Medical Care Facilities peers
Updated Jul 19, 2026
Gross Margin
17.63%
vs Medical Care Facilities peers
Updated Jul 19, 2026
Profit Margin
4.49%
vs Medical Care Facilities peers
Updated Jul 19, 2026
Operating Margin
8.45%
vs Medical Care Facilities peers
Updated Jul 19, 2026
Return on Assets (TTM)
4.27%
vs Medical Care Facilities peers
Updated Jul 19, 2026
Return on Equity (TTM)
27.11%
vs Medical Care Facilities peers
Updated Jul 19, 2026
Revenue (TTM)
5.43BUSD
vs all stocks (USD)
Updated Jul 19, 2026
Revenue per Share (TTM)
34.68USDUpdated Jul 19, 2026
Quarterly Revenue Growth
11.20%
vs Medical Care Facilities peers
Updated Jul 19, 2026
Gross Profit (TTM)
910.70MUSD
vs all stocks (USD)
Updated Jul 19, 2026
EBITDA (TTM)
444.37MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Net Income (TTM)
243.77MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Quarterly Earnings Growth (YoY)
183.40%
vs Medical Care Facilities peers
Updated Jul 19, 2026
Operating Cash Flow (TTM)
490.32MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Levered Free Cash Flow (TTM)
303.31MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Trailing Annual Dividend Rate
0.00USDUpdated Jul 19, 2026
Trailing Annual Dividend Yield
0.00%
vs all stocks
Updated Jul 19, 2026
Payout Ratio
0.00%
vs Medical Care Facilities peers
Updated Jul 19, 2026
Minority Interest (Equity)
5.68MUSDFY2025 · Dec 31, 2025
Revenue
5.29BUSDFY2025 · Dec 31, 2025
Cost of Goods Sold
4.51BUSDFY2025 · Dec 31, 2025
Gross Profit
780.33MUSDFY2025 · Dec 31, 2025
Operating Income
309.60MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
284.45MUSDFY2025 · Dec 31, 2025
Income Tax Expense
92.99MUSDFY2025 · Dec 31, 2025
Net Income
191.46MUSDFY2025 · Dec 31, 2025
EBIT
312.81MUSDFY2025 · Dec 31, 2025
EBITDA (Income Statement)
368.48MUSDFY2025 · Dec 31, 2025
Selling, General & Administrative
415.07MUSDFY2025 · Dec 31, 2025
Non-operating Interest Expense
28.36MUSDFY2025 · Dec 31, 2025
EPS (Basic)
1.23USDFY2025 · Dec 31, 2025
EPS (Diluted)
1.22USDFY2025 · Dec 31, 2025
Basic Shares Outstanding
156.18MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
156.18MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
191.46MUSDFY2025 · Dec 31, 2025
Minority Interests (P&L)
82.00KUSDFY2025 · Dec 31, 2025
Operating Cash Flow
343.04MUSDFY2025 · Dec 31, 2025
Free Cash Flow
93.89MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
232.05MUSDFY2025 · Dec 31, 2025
Income Tax Paid
84.05MUSDFY2025 · Dec 31, 2025
Interest Paid
40.51MUSDFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
191.46MUSDFY2025 · Dec 31, 2025
Depreciation & Amortization
55.66MUSDFY2025 · Dec 31, 2025
Deferred Taxes (CF)
-17.73MUSDFY2025 · Dec 31, 2025
Stock-based Compensation
54.07MUSDFY2025 · Dec 31, 2025
Other Non-cash Items
52.17MUSDFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
14.43MUSDFY2025 · Dec 31, 2025
Change in Accounts Payable (CF)
14.86MUSDFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-21.88MUSDFY2025 · Dec 31, 2025
Capital Expenditures
-249.16MUSDFY2025 · Dec 31, 2025
Net Acquisitions
0.00USDFY2025 · Dec 31, 2025
Purchase of Investments
-21.21MUSDFY2025 · Dec 31, 2025
Sale of Investments
0.00USDFY2025 · Dec 31, 2025
Other Investing Activity
750.00KUSDFY2025 · Dec 31, 2025
Net Investing Cash Flow
-269.62MUSDFY2025 · Dec 31, 2025
Long-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025
Long-term Debt Payments
-60.22MUSDFY2025 · Dec 31, 2025
Common Dividends Paid
0.00USDFY2025 · Dec 31, 2025
Other Financing Charges
-8.77MUSDFY2025 · Dec 31, 2025
Net Financing Cash Flow
-68.99MUSDFY2025 · Dec 31, 2025
Shares Outstanding
157.17MSharesUpdated Jul 19, 2026
Float Shares
47.98MSharesUpdated Jul 19, 2026
Shares Short
4.53MSharesUpdated Jul 19, 2026
Short Ratio
4.76days
vs all stocks
Updated Jul 19, 2026
Short % of Shares Outstanding
9.38%
vs all stocks
Provider-reported. Shares Short ÷ Shares Outstanding on this page gives 2.88%.Updated Jul 19, 2026
% Held by Insiders
69.53%
vs all stocks
Updated Jul 19, 2026
% Held by Institutions
30.45%
vs all stocks
Updated Jul 19, 2026
Total Cash (MRQ)
247.98MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Total Cash per Share (MRQ)
1.57USDUpdated Jul 19, 2026
Total Debt (MRQ)
3.51BUSD
vs all stocks (USD)
Updated Jul 19, 2026
Total Debt to Equity (MRQ)
3.36x
vs Medical Care Facilities peers
Updated Jul 19, 2026
Current Ratio (MRQ)
0.9950x
vs Medical Care Facilities peers
Updated Jul 19, 2026
Book Value per Share (MRQ)
6.60USDUpdated Jul 19, 2026
Total Assets
5.58BUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.07BUSDFY2025 · Dec 31, 2025
Total Liabilities
4.63BUSDFY2025 · Dec 31, 2025
Total Non-current Assets
4.51BUSDFY2025 · Dec 31, 2025
Total Non-current Liabilities
3.63BUSDFY2025 · Dec 31, 2025
Total Current Liabilities
1.00BUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents
197.02MUSDFY2025 · Dec 31, 2025
Accounts Receivable
628.13MUSDFY2025 · Dec 31, 2025
Accounts Payable
192.23MUSDFY2025 · Dec 31, 2025
Short-term Debt
186.46MUSDFY2025 · Dec 31, 2025
Long-term Debt
3.28BUSDFY2025 · Dec 31, 2025
Other Non-current Liabilities
152.94MUSDFY2025 · Dec 31, 2025
Common Stock (Book)
157.00KUSDFY2025 · Dec 31, 2025
Retained Earnings
309.58MUSDFY2025 · Dec 31, 2025
Total Shareholders' Equity
952.45MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
7.50USDUpdated Jul 19, 2026
52-Week High
47.17USDUpdated Jul 19, 2026
52-Week Change
296.98%
vs all stocks
Updated Jul 19, 2026
Beta
-0.0810x
vs all stocks
Updated Jul 19, 2026
50-Day MA
38.94USDUpdated Jul 19, 2026
200-Day MA
32.12USDUpdated Jul 19, 2026
Avg 10-Day Volume
896.11KSharesUpdated Jul 19, 2026
Avg 30-Day Volume
964.00KSharesUpdated Jul 19, 2026
Diluted EPS (TTM)
1.55USDUpdated Jul 19, 2026
Other Income / Expense
3.22MUSDFY2025 · Dec 31, 2025
4 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Its return on equity is high for the gross margin it earns, with revenue up three years and profit in all five.
Reads
Is this company growing?
Growth With Volume Backing
Revenue and net income have compounded over six years, and volume has leaned up with it.
Reads
Multi-Year Revenue And Profit Growth
Revenue and earnings have both grown steadily across six years.
Reads
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 2.17: grey zoneSignificant
Altman Z-Score: 2.17
Supply Chain
Downstream position: depends on 12 industries, supplies 7Notable
Outgoing: 7.00Incoming: 12.00
High connectivity hub: 19 industry connectionsNotable
Total Connections: 19.00
Scale
Market cap is $7.3B, above the global median of $1.15BNotable
Market cap (USD): 7,301,104,704Global Median: 1,146,734,693.424
Revenue is $5.43B, above the global median of $520.53MNotable